EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(2 sites)
Taiwan
National Taiwan University Hospital Hsinchu Branch, Hsinchu Shin Kong Wu Ho-Su Memorial Hospital, Taipei Age range
20 Years and older
Last updated December 2024